Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
07/04/2012 | EP2470535A2 Compositions, methods, and kits for determining an alkyl transferase |
07/04/2012 | EP2470190A1 Echinocandin derivatives |
07/04/2012 | CN1977043B Natural IgM antibodies and inhibitors thereof |
07/04/2012 | CN1703624B Methods and systems for detecting mhc class i and ii binding peptides |
07/04/2012 | CN102539779A Application of Vitamin D binding protein serving as marker of diabetes |
07/04/2012 | CN102532276A Cyclohexapeptide antibacterial compounds and preparation method thereof |
07/04/2012 | CN102532275A Cyclothiazomycin analogue generated by mutation of precursor peptide groups, and uses |
07/04/2012 | CN102532274A Method for preparing bivalirudin |
07/04/2012 | CN102532273A Natural antioxidant peptide Tiannanin-beta1 and preparation method and application thereof |
07/04/2012 | CN102532272A Polypeptide specifically combined with HepG2 cell surface |
07/04/2012 | CN102532271A Brucella B cell epitope and monoclonal antibody and application thereof |
07/04/2012 | CN102532270A Anti-oral cariogenic bacteria polypeptide Pm1 and preparation method |
07/04/2012 | CN102532269A Dominant sequence of delta 1 chain complementary determining region (CDR) 3 in gamma delta T lymphocytes, and T cell receptor (TCR) transfected cells and application thereof |
07/04/2012 | CN102532268A Oligopeptide with breast cancer resistant activity and application thereof |
07/04/2012 | CN102532267A Method for preparing icatibant |
07/04/2012 | CN102532266A Natural antioxidant peptide Macrotympanain-Al and preparation method and application thereof |
07/04/2012 | CN102532265A Gramicidin, isomer thereof and application thereof |
07/04/2012 | CN102532264A Peptide-based compounds |
07/04/2012 | CN102532263A Bi-component drug micromolecule hydrogel based on hexadecadrol and taxol and preparation method thereof |
07/04/2012 | CN102532197A First glass photoaffinity labeling difunctional probe molecule and preparation method and application thereof |
07/04/2012 | CN102526699A Methods for preventing and treating alzheimer's disease (AD) |
07/04/2012 | CN102127152B Antagonistic peptide of anti-opioid peptide and application thereof |
07/04/2012 | CN102127151B Antagonistic peptide of anti-opioid peptide and application thereof |
07/04/2012 | CN102127145B Substituted tetrahydroisoquinoline compound as well as preparation method and application thereof |
07/04/2012 | CN101948842B Heterometrus spinifer poison antibacterial polypeptide gene and preparation method and application thereof |
07/04/2012 | CN101948508B Tumor-resistance CTL (Cytotoxic T Lymphocyte) epitope peptide derived from PIWIL2 and application thereof |
07/04/2012 | CN101921317B Anti-freeze polypeptide prepared by utilizing papain to carry out enzymolysis to pigskin collagen |
07/04/2012 | CN101914136B Liquid-phase synthesis method for oxytocin |
07/04/2012 | CN101899096B Blood group A epitope mimic peptide and application thereof |
07/04/2012 | CN101870723B Short peptide and immunosuppressant containing the same and application thereof |
07/04/2012 | CN101792484B Anthracycline derivative of polypeptide containing tyrosine-isoleucine-glycine-serine-arginine |
07/04/2012 | CN101712716B Method for preparing vapreotide |
07/04/2012 | CN101659692B Method for preparing echinocandin B |
07/04/2012 | CN101607913B 改进的螯合剂缀合物 Improved chelator conjugate |
07/04/2012 | CN101230096B Peptide derived from hepatitis C virus |
07/04/2012 | CN101092455B Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
07/03/2012 | US8212002 Synthesis of glatiramer acetate |
07/03/2012 | CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2 |
06/28/2012 | WO2012087943A2 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction |
06/28/2012 | WO2012087925A1 Factor h binding peptides and uses thereof |
06/28/2012 | WO2012087913A2 Peptide reagents and methods for detection of colon dysplasia |
06/28/2012 | WO2012085177A1 Nemaucin, an antibiotic produced by entomopathogenic xenorhabdus cabanillasii |
06/28/2012 | WO2012085096A1 Peptides for treating cancer |
06/28/2012 | WO2012085090A1 Vaccines based on peptides of the complement protein c5a |
06/28/2012 | WO2012083872A1 Photoaffinity labeling double function probe molecule, preparation method and application thereof |
06/28/2012 | WO2012083861A1 Method for preparing atosiban acetate |
06/28/2012 | WO2012083475A1 Neutralizing polyclonal antibody against hantavirusandes, production method and pharmaceutical compositions |
06/28/2012 | WO2012083424A1 Novel amino acid linker sequences for ligand immobilization |
06/28/2012 | WO2012083385A1 Serine protease inhibitors |
06/28/2012 | WO2012036437A3 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease |
06/28/2012 | WO2012023781A9 Peptide having anti-red tide activities, and use thereof |
06/28/2012 | WO2012010946A3 Bnip3 isoforms and methods of use |
06/28/2012 | US20120165506 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
06/28/2012 | US20120165259 Agent for ameliorating blood-brain barrier disorders |
06/28/2012 | US20120165258 Compositions and Methods for Treatment of Thrombosis and for Prolonging Survival of Stored Platelets |
06/28/2012 | US20120165250 Active Cores of Peptide Triazole HIV-1 Entry Inhibitors |
06/28/2012 | US20120165249 Stabilized Therapeutic Small Helical Antiviral Peptides |
06/28/2012 | US20120164229 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
06/28/2012 | US20120164166 Neisseria meningitidis antigens and compositions |
06/28/2012 | US20120164165 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals |
06/28/2012 | US20120164163 Cdc45l peptides and vaccines including the same |
06/28/2012 | US20120164146 Isolated monophosphorylated peptide derived from human alpha-enolase useful for diagnosis and treatment of pancreatic adenocarcinoma, antibodies directed against the said monophosphorylated peptide, and uses thereof |
06/28/2012 | US20120164127 Mirac proteins |
06/28/2012 | CA2822460A1 Peptides for treating cancer |
06/28/2012 | CA2822266A1 Vaccines based on peptides of the complement protein c5a |
06/27/2012 | EP2468868A1 Chemotherapeutic sensitizers |
06/27/2012 | EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
06/27/2012 | EP2468295A1 Vaccines based on peptides of the complement protein C5a |
06/27/2012 | EP2468288A1 Peptides for treating cancer |
06/27/2012 | EP2467153A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
06/27/2012 | EP2246360B1 Compositions for the treatment of gastrointestinal disorders |
06/27/2012 | EP2086996B1 Marker specific for an oxidative degradation of tissues containing type iii collagen, means, methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by said marker |
06/27/2012 | EP1988163B1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
06/27/2012 | CN102516384A MLKL protein and application of MLKL protein as target point of cell necrosis inhibitor |
06/27/2012 | CN102516368A Cyclopeptide-7 compounds and application thereof in preparation of anti-tumor medicines |
06/27/2012 | CN102516367A Method for extracting high-purity microcystins |
06/27/2012 | CN102516366A Th1 cell factor immunoregulation polypeptide and application thereof |
06/27/2012 | CN102516365A Anti-HIV (human immunodeficiency virus) polypeptide of Tibetan dolphin scorpion |
06/27/2012 | CN102516364A Active peptide for simulating porcine growth hormone-like effect, preparation method for active peptide and application of active peptide |
06/27/2012 | CN102516363A CTL (Cytotoxic T Lymphocytes) epitope peptide from PL2L60 source and application thereof |
06/27/2012 | CN102516362A Method for preparing thymopentin |
06/27/2012 | CN102516361A NRP-1 ligand polypeptide-polyethylene glycol-phosphatide compound, active targeting liposome drug delivery system mediated thereby and preparation method thereof |
06/27/2012 | CN102516360A Polypeptide capable of inhibiting beta-secretase digestion effect and application thereof |
06/27/2012 | CN102516359A Novel anti-senile dementia lead compound |
06/27/2012 | CN102516358A Angiotensin I transferase inhibitor derived from scale collagen and application thereof |
06/27/2012 | CN102516357A Polypeptide combined with A-beta amyloid and application thereof |
06/27/2012 | CN102516356A Epitope polypeptide applicable to mycobacterium tuberculosis infection detection and application thereof |
06/27/2012 | CN102516355A Peptide derivative of benzfuran quinoline and preparation method thereof and application thereof as antitumor medicament |
06/27/2012 | CN102512658A Non-aqueous polar aprotic peptide formulations |
06/27/2012 | CN101906163B Immunocontraceptive synthetic peptide and immunocontraceptive chimeric peptide and application thereof |
06/27/2012 | CN101906147B Conjugate formed by two Arg-Gly-Asp-Ser chains and one fatty alcohol chain through Lys, synthesis thereof and application in medicine |
06/27/2012 | CN101870725B MAGE (Melanoma Antigen Gene)-4 anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof |
06/27/2012 | CN101838650B Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody |
06/27/2012 | CN101838308B Solid-phase synthesis method for eptifibatide |
06/27/2012 | CN101830970B Purification and preparation method of high-purity Daptomycin |
06/27/2012 | CN101497651B Compound with thrombus dissolving activity, as well as preparation and use thereof |
06/27/2012 | CN101333247B Antimicrobial peptide separated from skin of Northeast China brown frog and applications in antibacterials |
06/26/2012 | US8207314 Tumor antigens for prevention and/or treatment of cancer |
06/26/2012 | US8207299 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof |
06/26/2012 | US8207296 Approach to treat intraocular hypertension |